Redifferentiating Thyroid Cancer: Selumetinib-enhanced Radioiodine Uptake in Thyroid Cancer

In a recent article, we reported a restorative therapeutic intervention that turned individual thyroid cancer lesions into more efficient tissues for taking up radioactive iodine (RAI), resulting in clinically significant and durable responses. A group of Iodine-131 refractory thyroid cancer patient...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Imaging Radionucl Ther
Autors principals: Larson, Steven M., Osborne, Joseph R., Grewal, Ravinder K., Tuttle, R. Michael
Format: Artigo
Idioma:Inglês
Publicat: Galenos Publishing 2017
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5283711/
https://ncbi.nlm.nih.gov/pubmed/28117292
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4274/2017.26.suppl.09
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars